Complementary and alternative medicine use among patients with thyroid cancer.

Complementary and alternative medicine use among patients with thyroid cancer.
复制标题

甲状腺癌患者的补充和替代药物的使用。

DOI:
10.1089/thy.2012.0495
复制
发表时间:
2013
期刊:
Thyroid : official journal of the American Thyroid Association
影响因子:
--
通讯作者:
Lee,StephanieL
Lee,StephanieL
中科院分区:
--
文献类型:
--
作者:
Rosen,JenniferE;Gardiner,Paula;Saper,RobertB;Filippelli,AmandaC;White,LauraF;Pearce,ElizabethN;Gupta-Lawrence,RebeccaL;Lee,StephanieL

文献摘要

参考文献

被引文献

相似文献

背景:报告甲状腺癌患者使用补充和替代药物(CAM)的发生率和预测因素。方法:通过波士顿大学机构审查委员会批准的网上匿名调查收集数据。这份报告是基于1327名甲状腺癌患者的回答。结果:排除复合维生素和祈祷的使用后,74%(n=941)的患者使用了CAM。受访者主要是40岁以上的白人和女性,并拥有大学学位。排在前五位的方式是按摩疗法、手感疗法、特殊饮食、草药茶和瑜伽。很少有患者报告认为一种特定的治疗方式对治疗有负面影响。CAM更多地用于症状治疗(73%),而不是作为甲状腺癌治疗的一部分(27%)。多变量Logistic回归分析显示,健康状况不佳、受教育程度较高、心血管疾病、肺部症状、或持续性、复发性或转移性疾病的患者更有可能使用CAM来治疗甲状腺癌症状。近三分之一的受访者报告说,他们的医生不知道、开出或询问他们的CAM使用情况。结论:与对美国普通人群的全国性调查相比,甲状腺癌患者使用CAM疗法的频率是前者的两倍,而他们报告的使用频率要低得多。治疗甲状腺癌患者的医生应该意识到这些数据,以进一步帮助他们评估和护理。
Background:To report on the incidence and predictors of use of complementary and alternative medicine (CAM) among patients with thyroid cancer.Methods:Data were collected using a web-based online anonymous survey under Institutional Review Board approval from Boston University. This report is based on 1327 responses from subjects with thyroid cancer. Patient factors were compared by univariate and multivariate analyses.Results:After excluding multivitamin and prayer use, 74% (n=941) used CAM. Respondents were primarily over age 40, white, and female and held a college degree. The top five modalities were massage therapy, chiropraxy, special diets, herbal tea, and yoga. Few patients reported perceiving a particular modality had a negative effect on treatment. CAM was more often used for treatment of symptoms (73%) than as part of thyroid cancer treatment (27%). Multivariable logistic regression demonstrated that patients reporting a poor health status, higher education, cardiovascular disease, pulmonary symptoms, or persistent, recurrent, or metastatic disease were more likely to use CAM for treatment of thyroid cancer symptoms. Nearly one third of respondents reported their CAM use was not known, prescribed, or asked about by their physicians.Conclusions:In comparison to national surveys of the general U.S. population, patients with thyroid cancer use CAM therapies twice as often and report their use far less often. Physicians who treat patients with thyroid cancer should be aware of these data to further assist in their assessment and care.
DOI: 10.1016/j.ejca.2006.02.019
发表时间: 2006-08-01
影响因子: 8.4
作者:
Baum, Michael;Cassileth, Barrie R.;Smith, Wendy B.
通讯作者: Smith, Wendy B.
草药和其他膳食补充剂:医疗保健专业人员的知识、态度和实践。
DOI: --
发表时间: 2003
影响因子: 1.5
作者:
Kemper,KathiJ;Amata-Kynvi,Andey;Dvorkin,Lana;Whelan,JuliaS;Woolf,Alan;Samuels,RonaldC;Hibberd,Patricia
通讯作者: Hibberd,Patricia
患有乳腺癌的女性使用补充和替代医学。
DOI: 10.1525/maq.1999.13.2.214
发表时间: 1999
影响因子: 2.2
作者:
Adler,SR
通讯作者: Adler,SR
DOI: 10.1097/00003727-200301000-00003
发表时间: 2003-01-01
影响因子: 2.3
作者:
Canales, MK;Geller, BM
通讯作者: Geller, BM
重复测量自我报告的药物使用情况的测量偏差估计,并应用于全国家庭药物滥用调查。
DOI: 10.1037/e495622006-021
发表时间: 1997
期刊: NIDA research monograph
影响因子: --
作者:
Paul Biemer;Michael Witt
通讯作者: Michael Witt